Y-mAbs Therapeutics, Inc. Accounts Payable
Y-mAbs Therapeutics, Inc. had Accounts Payable of $7.57 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-08-08
- 2025-06-30: Accounts Payable, Current $7.57M.
- 2025-03-31: Accounts Payable, Current $4.63M.
- 2024-12-31: Accounts Payable, Current $6.66M.
- 2024-09-30: Accounts Payable, Current $7.88M.
| Period end | Accounts Payable, Current |
|---|---|
| 2025-06-30 | $7.57M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $4.63M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $6.66M 10-Q · filed 2025-08-08 |
| 2024-09-30 | $7.88M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $10.19M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $6.73M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $6.06M 10-K · filed 2025-03-04 |
| 2023-09-30 | $7.61M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $7.25M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $8.84M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $14.18M 10-K · filed 2024-02-29 |
| 2022-09-30 | $13.72M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $11.29M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $14.66M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $13.55M 10-K · filed 2023-03-30 |
| 2021-09-30 | $11.02M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $6.80M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $6.54M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $9.37M 10-K · filed 2022-03-01 |
| 2020-09-30 | $10.32M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $9.82M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $10.26M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $8.52M 10-K · filed 2021-03-01 |
| 2019-09-30 | $7.63M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $8.91M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $5.91M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $5.87M 10-K · filed 2020-03-12 |
| 2018-09-30 | $6.83M 10-Q · filed 2018-11-13 |
| 2017-12-31 | $5.91M 10-K · filed 2019-03-22 |